Global Positron Emission Tomography Market Size study & Forecast, by Product (PET/CT Systems, PET/MRI Systems) by Application (Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications), by End User (Hospital & Surg

Global Positron Emission Tomography Market Size study & Forecast, by Product (PET/CT Systems, PET/MRI Systems) by Application (Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications), by End User (Hospital & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users) and Regional Analysis, 2023-2030

Global Positron Emission Tomography Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Positron Emission Tomography (PET) is a mix of nuclear medicine and biochemical analysis that is used to measure the metabolic activity of cells. Through an intravenous (IV) line, an insignificant quantity of radioactive glucose (sugar) is injected into the patient's vein. A scanner and computer are used to create detailed images of places containing glucose. PET is used for the early identification of heart diseases, brain disorders, and cancer. The key factor driving the market growth is the growing target patient population, rising adoption of multimodal PET imaging devices, technological advancements in radiopharmaceuticals and PET systems, and rising investments, funds, and grants by public-private organizations that are anticipated to create the lucrative demand for the market.

Moreover, the rising prevalence of cardiovascular diseases has significantly contributed to the growth of the Positron Emission Tomography (PET) market. PET imaging plays a crucial role in the diagnosis and management of cardiovascular diseases. It provides detailed functional and anatomical information about the heart and blood vessels, allowing for the early detection and assessment of cardiovascular conditions. Thus, the rising prevalence of cardiovascular diseases is anticipated to support market growth. according to the research study published in December 2021, by Elsevier, for older people aged 45 and above, the overall self-reported prevalence of CVDs was 29.4%. The prevalence rate increased with age, from 22% in the 45–54 age group to 38% in the 70+ age group, showing that the old age population is at high risk of having CVDs. Additionally, the rising use of PET in breast cancer detection and improving healthcare infrastructure across emerging economies is anticipated to create a lucrative opportunity for the market during the forecast period. However, the availability of alternate imaging technologies stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Positron Emission Tomography Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing geriatric population, focus on reducing healthcare costs and government investments, and increasing prevalence of cancer in the region. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising adoption of advanced technologies, improving healthcare infrastructure, presence of advanced healthcare system, and rising investments in research and development.

Major market player included in this report are:
G.E. Healthcare
Toshiba Corporation
Koninklijke Philips N.V.
Siemens Healthineers
Hitachi Medical Corporation
Positron Corporation
Mediso Ltd.
Yangzhou Kindsway Biotech Co., Ltd
Agfa Healthcare
Neusoft Corporation

Recent Developments in the Market:
In Aug. 2022, Positron Corporation, a nuclear medicine PET imaging device system and clinical services provider, had ordered its first PET-CT system from Neusoft Medical Systems. Positron's ""Affinity PET-CT"" equipment is on its way from China to its US validation partner.

Global Positron Emission Tomography Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Product, Application, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
PET/CT Systems
PET/MRI Systems
By Application:
Oncology Applications
Neurological Applications
Cardiovascular Applications
Other Applications
By End User:
Hospital & Surgical Centers
Diagnostic & Imaging Clinics
Ambulatory Care Centers
Other End Users
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
G.E. Healthcare
Toshiba Corporation
Koninklijke Philips N.V.
Siemens Healthineers
Hitachi Medical Corporation
Positron Corporation
Mediso Ltd.
Yangzhou Kindsway Biotech Co., Ltd
Agfa Healthcare
Neusoft Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.